Robert W. Ross

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Kevin Brennan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Robert W. Ross:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 31,000 11 Jun 2025 Direct
Surface Oncology, Inc. Chief Executive Officer, Director Common Stock 0 $0.9400 08 Sep 2023 Direct
Surface Oncology, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 08 Sep 2023 Direct

Insider Reports Filed by Robert W. Ross

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XLO Xilio Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:37
XLO Xilio Therapeutics, Inc. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 16:30
/report/000120919123048757-ross-robert-w-2023-09-08 Surface Oncology, Inc. 08 Sep 2023 2 $0 4 Chief Executive Officer, Director 08 Sep 2023, 16:00
/report/000120919123045494-ross-robert-w-2023-08-01 Surface Oncology, Inc. 01 Aug 2023 1 -$15,710 4 Chief Executive Officer 11 Aug 2023, 20:00
XLO Xilio Therapeutics, Inc. 12 Jun 2023 1 $0 4 Director 13 Jun 2023, 16:30
/report/000120919123016052-ross-robert-w-2023-03-01 Surface Oncology, Inc. 01 Mar 2023 1 $0 4 Chief Executive Officer 03 Mar 2023, 19:00
/report/000120919122044673-ross-robert-w-2022-08-03 Surface Oncology, Inc. 03 Aug 2022 1 -$18,222 4 Chief Executive Officer 05 Aug 2022, 20:00
XLO Xilio Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:08
XLO Xilio Therapeutics, Inc. 15 Jun 2022 0 $0 3 Director 17 Jun 2022, 16:06
/report/000120919122015966-ross-robert-w-2022-03-01 Surface Oncology, Inc. 01 Mar 2022 2 $0 4 Chief Executive Officer 03 Mar 2022, 19:00
/report/000120919122003397-ross-robert-w-2021-07-21 Surface Oncology, Inc. 21 Jul 2021 1 -$204,350 4 Chief Executive Officer 14 Jan 2022, 19:30

Sponsored